These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 39427012)

  • 1. Expression of c-erb-B2 oncoprotein as a neoantigen strategy to repurpose anti-neu antibody therapy in a model of melanoma.
    Gabriel EM; Necela B; Bahr D; Vivekanandhan S; Shreeder B; Bagaria S; Knutson KL
    Sci Rep; 2024 Oct; 14(1):24545. PubMed ID: 39427012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of c-erb-B2 oncoprotein as a neoantigen strategy to repurpose anti-neu antibody therapy in a model of melanoma.
    Gabriel EM; Necela B; Bahr D; Vivekanandhan S; Shreeder B; Bagaria S; Knutson KL
    Res Sq; 2024 Apr; ():. PubMed ID: 38645250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced pancreatic cancer gene therapy by combination of adenoviral vector expressing c-erb-B2 (Her-2/neu)-targeted immunotoxin with a replication-competent adenovirus or etoposide.
    Liu X; Li J; Tian Y; Xu P; Chen X; Xie K; Qiu Z; Wang Y; Zhang D; Wolf F; Li C; Huang Q
    Hum Gene Ther; 2010 Feb; 21(2):157-70. PubMed ID: 19751100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with a HSP65-HER2 fusion peptide selectively eliminates HER2(+) B16 melanoma cells in a xenograft tumor mouse model.
    Wang J; Wang X; Chen Y; Wan M; Xiang Z; Wu X; Wei H; Wang L; Zhang P; Wang L; Yu Y
    Tumour Biol; 2013 Feb; 34(1):193-201. PubMed ID: 23055194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumoral heterogeneity impacts the response to anti-neu antibody therapy.
    Song H; Kim TO; Ma SY; Park JH; Choi JH; Kim JH; Kang MS; Bae SK; Kim KH; Kim TH; Seo SK; Choi IW; Song GA; Mortenson ED; Fu YX; Park S
    BMC Cancer; 2014 Sep; 14():647. PubMed ID: 25179116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine monoclonal anti-idiotypic antibody as a surrogate antigen for human Her-2/neu.
    Baral R; Sherrat A; Das R; Foon KA; Bhattacharya-Chatterjee M
    Int J Cancer; 2001 Apr; 92(1):88-95. PubMed ID: 11279611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-erb-B2 (HER2/neu) expression in synovial sarcoma of the head and neck.
    Olsen RJ; Lydiatt WM; Koepsell SA; Lydiatt D; Johansson SL; Naumann S; Bridge JA; Neff JR; Hinrichs SH; Tarantolo SR
    Head Neck; 2005 Oct; 27(10):883-92. PubMed ID: 16158422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Therapeutic Her2/neu Vaccine Targeting Dendritic Cells Preferentially Inhibits the Growth of Low Her2/neu-Expressing Tumor in HLA-A2 Transgenic Mice.
    Tran T; Diniz MO; Dransart E; Gey A; Merillon N; Lone YC; Godefroy S; Sibley C; Ferreira LC; Medioni J; Oudard S; Johannes L; Tartour E
    Clin Cancer Res; 2016 Aug; 22(16):4133-44. PubMed ID: 27006496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of rat-neu
    Sow HS; Benonisson H; Brouwers C; Linssen MM; Camps M; Breukel C; Claassens J; van Hall T; Ossendorp F; Fransen MF; Verbeek JS
    Sci Rep; 2020 Mar; 10(1):3933. PubMed ID: 32127568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Ad5[E1-, E2b-]-HER2/neu vector induces immune responses and inhibits HER2/neu expressing tumor progression in Ad5 immune mice.
    Gabitzsch ES; Xu Y; Balcaitis S; Balint JP; Jones FR
    Cancer Gene Ther; 2011 May; 18(5):326-35. PubMed ID: 21233857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene.
    Menendez JA; Vellon L; Lupu R
    Ann Oncol; 2005 Aug; 16(8):1253-67. PubMed ID: 15870086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting of the non-mutated tumor antigen HER2/neu to mature dendritic cells induces an integrated immune response that protects against breast cancer in mice.
    Wang B; Zaidi N; He LZ; Zhang L; Kuroiwa JM; Keler T; Steinman RM
    Breast Cancer Res; 2012 Mar; 14(2):R39. PubMed ID: 22397502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tumor immunity induced by an anti-idiotype antibody mimicking human Her-2/neu.
    Mohanty K; Saha A; Pal S; Mallick P; Chatterjee SK; Foon KA; Bhattacharya-Chatterjee M
    Breast Cancer Res Treat; 2007 Jul; 104(1):1-11. PubMed ID: 17004107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-erb B2 (Her2/neu) is neither overexpressed nor amplified in hepatic neoplasms.
    Vlasoff DM; Baschinsky DY; De Young BR; Morrison CD; Nuovo GJ; Frankel WL
    Appl Immunohistochem Mol Morphol; 2002 Sep; 10(3):237-41. PubMed ID: 12373150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraoperative imaging of metastatic lymph nodes using a fluorophore-conjugated antibody in a HER2/neu-expressing orthotopic breast cancer mouse model.
    Wu J; Ma R; Cao H; Wang Z; Jing C; Sun Y; Zhang Y; Yang Z; Hoffman RM; Tang J
    Anticancer Res; 2013 Feb; 33(2):419-24. PubMed ID: 23393332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased survival of human breast cancer cells expressing HER2/neu on in vitro incubation with an anti-HER2/neu antibody fused to C5a or C5a desArg.
    Fuenmayor J; Perez-Vazquez K; Perez-Witzke D; Penichet ML; Montano RF
    Mol Cancer Ther; 2010 Aug; 9(8):2175-85. PubMed ID: 20682652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfection of rat ovarian surface epithelium with erb-B2/neu induces transformed phenotypes in vitro and the tumorigenic phenotype in vivo.
    Davies BR; Auersperg N; Worsley SD; Ponder BA
    Am J Pathol; 1998 Jan; 152(1):297-306. PubMed ID: 9422547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-beta1 and C-erb-B2 neu oncoprotein in Egyptian HCV related chronic liver disease and hepatocellular carcinoma patients.
    El Bassuoni MA; Talaat RM; Ibrahim AA; Shaker OT
    Egypt J Immunol; 2008; 15(1):39-50. PubMed ID: 20306668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant effect of HER-2/neu-specific adenoviral vector stimulating CD8⁺ T and natural killer cell responses on anti-HER-2/neu antibody therapy for well-established breast tumors in HER-2/neu transgenic mice.
    Chen Y; Xie Y; Chan T; Sami A; Ahmed S; Liu Q; Xiang J
    Cancer Gene Ther; 2011 Jul; 18(7):489-99. PubMed ID: 21566669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single low dose of dendritic cells modified with lentivirus containing a truncated neu gene can effectively suppress neu-overexpressing tumors.
    Li GB; Lu GX
    J Gene Med; 2010 Jul; 12(7):604-12. PubMed ID: 20533530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.